Does Omega-3 Lower Risk of Alzheimer’s Disease?

People with a higher omega-3 DHA level are 49% less likely to develop Alzheimer’s disease. Simple dietary intervention can work better.

Highlights:

People with a higher blood DHA level are 49% less likely to develop Alzheimer’s disease (AD)
Providing extra dietary omega-3 DHA for people carrying the ApoE4 gene can slow the disease progression
Simple dietary intervention could amount to billions in health care cost savings

People with a higher omega-3 DHA levels in the blood were found to be 49 percent less likely to develop Alzheimer’s disease (AD), reveals the Fatty Acid Research Institute (FARI) research published in Nutrients. //

The study, led by Aleix Sala-Vila, PhD, suggested that providing extra dietary omega-3 DHA, especially for those carrying the ApoE4 gene (which approximately doubles an individual’s susceptibility to develop AD) might slow the development of the disease.

Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death.

‘Delaying AD by 5 years leads to 2.7 additional years of life, and 4.8 additional AD-free years for an individual who would have acquired AD and is worth over $500,000.’

Such a cost-effective, low-risk dietary intervention like this could potentially save billions in health care costs.

Link Between DHA and Alzheimer’s Disease

In this prospective observational study conducted within the Framingham Offspring Cohort — including 1490 dementia-free participants aged ≥65 years old — researchers examined the association of red blood cell (RBC) docosahexaenoic acid (DHA) with incident Alzheimer’s Disease (AD), while also testing for an interaction with APOE-ε4 carriership.

Risk for incident AD in the highest RBC DHA quintile (Q5, >6.1%) was 49% lower compared with the lowest quintile (Q1, <3.8%). An increase in RBC DHA from Q1 to Q5 was predicted to provide an estimated 4.7 additional years of life free of AD.

Modified Atkins Diet: All You Need to Know
Modified Atkins diet designed for weight loss and to treat seizures is high in fat and low in carbohydrates. Discover how this diet is different from the ketogenic diet.

Further, the researchers noted that an increased intake of DHA might lower risk for developing AD, particularly in higher-risk individuals such as those carrying the APOE-ε4 allele, suggesting that they may benefit more from higher DHA levels than non-carriers.

The public health impact of preventing AD with something as simple as a dietary intervention like DHA is also significant.

Watch Out: Being Too Kind May Up Alzheimer's Disease in Elderly
Being too kind is bad for older people's brain health. Kind and more agreeable elderly people are more likely to develop memory-robbing diseases like Alzheimer's disease.

The researchers noted that “Given that estimated health-care payments in 2021 for all patients with AD or other dementias amount to $355 billion in the US (not including caregiving by family members and other unpaid caregivers), any cost-effective strategy for delaying the onset of AD is of utmost public health interest,” and that “Delaying AD by 5 years leads to 2.7 additional years of life, and 4.8 additional AD-free years for an individual who would have acquired AD and is worth over $500,000.”

So how does this paper stack up to others in this area? “Our study is in line with that of Tan et al. who reported cross-sectional associations with RBC DHA on cognitive performance and brain volume measurements (with higher DHA being associated with beneficial outcomes) in the same cohort as studied here,” said William S. Harris, PhD, President of FARI, and senior author on this recent study.

Risk Factors for Alzheimers Disease
Cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in the brain are more likely to develop Alzheimer’s disease.

“Most interestingly, 15 years ago similar findings were reported by Schaefer et al. in the parents of the individuals who were the focus of this present investigation (i.e., the Original Framingham Heart Study cohort). Schaefer et al. reported that participants in the top quartile of plasma phosphatidylcholine DHA experienced a significant, 47% reduction in the risk of developing all-cause dementia compared with those with lower levels,” Dr. Harris continued.

“Similar findings a generation apart in a similar genetic pool provide considerable confirmation of this DHA-dementia relationship.”

Source-Eurekalert